Seres Therapeutics

IPO

Establishing a Better Microbiome for Better Health

Public · Cambridge, United States · Founded 2010 · $154.5M raised

Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$154.5M
Last Round
$134.0M Venture RoundJun 2015
Rounds
3
Type
Public

About

Seres Therapeutics is a clinical-stage biotechnology company developing new therapies comprised of rationally selected live bacteria consortia. The company works to treat a wide range of diseases by modulating the composition and function of the human microbiome. Its team pioneered the development and FDA approval of VOWST, the first oral live biotherapeutic, which was sold to Nestlé Health Science in September 2024. Seres continues to advance a pipeline of live biotherapeutics for serious diseases.

Summary

Seres Therapeutics is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $154.5M in total across 3 rounds, most recently a $134.0M Venture Round round in Jun 2015. Investors include Nestlé Health Science, ARCH Venture Partners and New Enterprise Associates.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2015
$134.0M

Sign up to see all 3 rounds

Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seres Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/seres-therapeutics"><img src="https://indexed.vc/api/badge/company/seres-therapeutics" alt="Seres Therapeutics on Indexed.vc" width="260" height="76" /></a>